The Lack of Cardiovascular Risk Factor Management in Patients with Critical Limb Ischaemia
Authors:
- L KlitfodLKL Klitfod
- H SillesenHSH Sillesen
- 1 February 2001
- journal article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 21 (2) , 143-146
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cholesterol in peripheral vascular diseasea suitable case for treatment?QJM: An International Journal of Medicine, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- Incidence, Natural History and Cardiovascular Events in Symptomatic and Asymptomatic Peripheral Arterial Disease in the General PopulationInternational Journal of Epidemiology, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Coronary Artery Disease in Peripheral Vascular PatientsAnnals of Surgery, 1984
- TREATMENT OF HYPERLIPIDAEMIA RETARDS PROGRESSION OF SYMPTOMATIC FEMORAL ATHEROSCLEROSIS A Randomised Controlled TrialThe Lancet, 1983
- The treatment of intermittent claudication with beta-pyridyl carbinol over two yearsAtherosclerosis, 1973